| Marymount Manor | |
| 313 Augustine Rd, Po Box 600, Eureka, Missouri 63025 | |
| (636) 938-6770 | |
| Name | Marymount Manor |
|---|---|
| Location | 313 Augustine Rd, Po Box 600, Eureka, Missouri |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 174 |
| Occupancy Rate | 33.1% |
| Medicare ID (CCN) | 265140 |
| Legal Business Name | Marymount Manor Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1457412587 |
| Organization Name | MARYMOUNT MANOR LLC |
| Address | 313 Augustine Rd, Eureka, MO 63025 |
| Phone Number | 636-938-6770 |
News Archive
A new biodegradable material which could help regenerate spinal cord tissue without invasive surgery is being developed by Monash University PhD student, Ms Rosalyn Jackson.
An international research team , including investigators from Massachusetts General Hospital (MGH) and the Broad Institute of Harvard University and Massachusetts Institute of Technology, has identified several novel genetic variations associated with the risk of Crohn's disease.
In recent years, a powerful suite of drugs known as kinase inhibitors have been developed to treat cancer and other diseases. Primary targets of such drugs include a family of receptor tyrosine kinases (RTKs) which protrude from cell surfaces like antennae and can activate cancer-related pathways in virtually all types of cancer when signaling molecules bind with them.
CD74 is a protein that is expressed in and on cells of the immune system, such as B lymphocytes and antigen presenting cells. This protein is known for its function in facilitating antigen presentation enabling the immune response. Additionally, Professor Shachar's lab has previously shown that CD74 serves as a survival receptor on cells of the immune system, and that its stimulation by its natural ligand -migration inhibitory factor (MIF)- prevents apoptosis (self destruction) of these cells. It was shown that CD74 is markedly expressed on numerous tumors - hematologic as well as epithelial, and can serve as a prognostic marker. CD74's expression and function on colon intestinal epithelial cells is controversial.
› Verified 6 days ago
| NPI Number | 1982689485 |
| Organization Name | MID AMERICA HEALTHCARE LP |
| Doing Business As | MARYMOUNT MANOR SKILLED NURSING FACILITY |
| Address | 313 Augustine Rd, Eureka, MO 63025 |
| Phone Number | 636-938-6770 |
News Archive
A new biodegradable material which could help regenerate spinal cord tissue without invasive surgery is being developed by Monash University PhD student, Ms Rosalyn Jackson.
An international research team , including investigators from Massachusetts General Hospital (MGH) and the Broad Institute of Harvard University and Massachusetts Institute of Technology, has identified several novel genetic variations associated with the risk of Crohn's disease.
In recent years, a powerful suite of drugs known as kinase inhibitors have been developed to treat cancer and other diseases. Primary targets of such drugs include a family of receptor tyrosine kinases (RTKs) which protrude from cell surfaces like antennae and can activate cancer-related pathways in virtually all types of cancer when signaling molecules bind with them.
CD74 is a protein that is expressed in and on cells of the immune system, such as B lymphocytes and antigen presenting cells. This protein is known for its function in facilitating antigen presentation enabling the immune response. Additionally, Professor Shachar's lab has previously shown that CD74 serves as a survival receptor on cells of the immune system, and that its stimulation by its natural ligand -migration inhibitory factor (MIF)- prevents apoptosis (self destruction) of these cells. It was shown that CD74 is markedly expressed on numerous tumors - hematologic as well as epithelial, and can serve as a prognostic marker. CD74's expression and function on colon intestinal epithelial cells is controversial.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A new biodegradable material which could help regenerate spinal cord tissue without invasive surgery is being developed by Monash University PhD student, Ms Rosalyn Jackson.
An international research team , including investigators from Massachusetts General Hospital (MGH) and the Broad Institute of Harvard University and Massachusetts Institute of Technology, has identified several novel genetic variations associated with the risk of Crohn's disease.
In recent years, a powerful suite of drugs known as kinase inhibitors have been developed to treat cancer and other diseases. Primary targets of such drugs include a family of receptor tyrosine kinases (RTKs) which protrude from cell surfaces like antennae and can activate cancer-related pathways in virtually all types of cancer when signaling molecules bind with them.
CD74 is a protein that is expressed in and on cells of the immune system, such as B lymphocytes and antigen presenting cells. This protein is known for its function in facilitating antigen presentation enabling the immune response. Additionally, Professor Shachar's lab has previously shown that CD74 serves as a survival receptor on cells of the immune system, and that its stimulation by its natural ligand -migration inhibitory factor (MIF)- prevents apoptosis (self destruction) of these cells. It was shown that CD74 is markedly expressed on numerous tumors - hematologic as well as epithelial, and can serve as a prognostic marker. CD74's expression and function on colon intestinal epithelial cells is controversial.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 7.79 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 24.86 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 25.68 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 6.62 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 5.94 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 6.88 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.2 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 21.46 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 14.93 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 42.86 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 19.56 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 16.83 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 10.34 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 73.6 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 87.11 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 54.75 | 82.93 |
News Archive
A new biodegradable material which could help regenerate spinal cord tissue without invasive surgery is being developed by Monash University PhD student, Ms Rosalyn Jackson.
An international research team , including investigators from Massachusetts General Hospital (MGH) and the Broad Institute of Harvard University and Massachusetts Institute of Technology, has identified several novel genetic variations associated with the risk of Crohn's disease.
In recent years, a powerful suite of drugs known as kinase inhibitors have been developed to treat cancer and other diseases. Primary targets of such drugs include a family of receptor tyrosine kinases (RTKs) which protrude from cell surfaces like antennae and can activate cancer-related pathways in virtually all types of cancer when signaling molecules bind with them.
CD74 is a protein that is expressed in and on cells of the immune system, such as B lymphocytes and antigen presenting cells. This protein is known for its function in facilitating antigen presentation enabling the immune response. Additionally, Professor Shachar's lab has previously shown that CD74 serves as a survival receptor on cells of the immune system, and that its stimulation by its natural ligand -migration inhibitory factor (MIF)- prevents apoptosis (self destruction) of these cells. It was shown that CD74 is markedly expressed on numerous tumors - hematologic as well as epithelial, and can serve as a prognostic marker. CD74's expression and function on colon intestinal epithelial cells is controversial.
› Verified 6 days ago